5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5-d4

Modify Date: 2024-01-12 14:46:17

5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5-d4 structure	Common Name	5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5-d4
	CAS Number	252976-11-7	Molecular Weight	368.50
	Density	1.2±0.1 g/cm3	Boiling Point	544.5±50.0 °C at 760 mmHg
	Molecular Formula	C₂₁H₂₈D₄O₅	Melting Point	N/A
	MSDS	N/A	Flash Point	297.1±26.6 °C

Use of 5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5-d4

5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5-d4 is the deuterium labeled 5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5[1].

Name	5a-pregnan-11b,17a,21-triol-3,20-dione-1,2,4,5-d4
Synonym	More Synonyms

Description	5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5-d4 is the deuterium labeled 5α-Pregnan-11β,17α,21-triol-3,20-dione-1,2,4,5[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

(5α,11β)-11,17,21-Trihydroxy(1,2,4,5-H)pregnane-3,20-dione

Pregnane-3,20-dione-1,2,4,5-d, 11,17,21-trihydroxy-, (5α,11β)-